Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

NCT06786208 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

55

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Sunvozertinib

Sponsor

Henan Cancer Hospital